Journal of clinical psychopharmacology
International Standard Serial Number (ISSN)
publication venue for
Outcomes for Latin American versus White patients suffering from acute mania in a randomized, double-blind trial comparing olanzapine and haloperidol.
Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features.
Olanzapine versus placebo in acute mania: treatment responses in subgroups.
Acute dysphoric mania: treatment response to olanzapine versus placebo.
Treatment of bipolar I rapid cycling patients during dysphoric mania with olanzapine.
Interactive model of therapeutic response in panic disorder: moclobemide, a case in point.
Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder.
A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania.
Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: results of a multicenter, collaborative trial in Latin America.
Do antidepressants selectively suppress spontaneous (unexpected) panic attacks? A replication.
International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. Therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders.
International Study of Expert Judgement on Therapeutic Use of Benzodiazepines and Other Psychotherapeutic Medications: V. Treatment strategies in panic disorder, 1992-1997.
Issues in the long-term treatment of panic disorder.
Moclobemide in social phobia: a controlled dose-response trial.
Neurologic factors predict a favorable valproate response in bipolar and schizoaffective disorders.
Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders.
Preference for diazepam in anxious adults.
Risks and benefits of long-term benzodiazepine use.
Long-term response to carbamazepine: a retrospective study.
The value of self-report assessment in studies of anxiety disorders.
Plasma concentrations of imipramine and clinical response among depressed outpatients.
Dispelling myths about benzodiazepines.